9.1. NEED TO CONSTANTLY MAINTAIN AND DEVELOP THE CODE

The expansion in the arsenal of methods and means of marketing practice and their modification under the conditions of Russia’s developing pharmaceutical market leads to the need to constantly maintain and develop the Code so that it meets the demands of the times and does not have gaps in the regulation of advertising and other methods of promotion of pharmaceutical products.

9.2. ANALYSIS OF PHARMACEUTICAL COMPANY PRACTICES AND OPERATION OF THE CODE

In order to maintain the currency of the Code and its Appendices, as well as for the timely identification of the need to introduce amendments and additions, analysis of current marketing practices of pharmaceutical companies in the Russian market and of their interactions with healthcare professionals and patient organizations will be conducted. The analysis will include an evaluation of the conformity of marketing practices of companies manufacturing pharmaceutical products to the standards and principles of the Code, how completely the methods and means of advertising and promotion used are reflected in the Code, the identification of trends in regard to the most often violated principles, an evaluation of the influence of the standards of the Code on marketing practices, etc.

The analysis of the functioning of the Code will be carried out by the AIPM Ethics Committee.

9.3. UPDATING THE CODE

On the basis of the analysis conducted, the AIPM Ethics Committee will present an annual report to the Board of Directors. If necessary, the Ethics Committee will develop proposals on improvement of the Code and gives them to the Executive Director of the AIPM.